Latest Oxaliplatin Stories
- Data support VAL-083's importance as a potential therapy for non-small cell lung cancer (NSCLC), including drug-resistant NSCLC - VANCOUVER, British Columbia and MENLO PARK, Calif.,
THOUSAND OAKS, Calif., Feb.
SAN DIEGO, Feb.
Exploratory Analysis of Phase 2 Trial Shows Earlier and Sustained Responses in Patients Treated With Vectibix Versus Bevacizumab THOUSAND OAKS, Calif., Jan.
RnRMarketResearch.com adds “Nintedanib (Colorectal Cancer) – Forecast and Market Analysis to 2023” to its store.
RnRMarketResearch.com adds “Zaltrap (Colorectal Cancer) – Forecast and Market Analysis to 2023” to its store.
Generics Division of Sanofi, Winthrop US, to Market the Drug BRIDGEWATER, N.J., Aug.
The new combination agent TAS-102 is able to improve overall survival compared to placebo in patients whose metastatic colorectal cancer is refractory to standard therapies.
Study Shows Improved Survival Benefit in Panitumumab Arm THOUSAND OAKS, Calif., May 31, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced results from the Phase 2 PEAK study that reinforce
New Data Reinforces Commitment to Personalized Medicine and Highlights Advances in Immunotherapy Platform THOUSAND OAKS, Calif.
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.